Applied Finance Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Applied Finance Capital Management, LLC
- $2.3 Trillion
- Q4 2024
A detailed history of Applied Finance Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 28,317 shares of REGN stock, worth $19 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
28,317
Previous 28,263
0.19%
Holding current value
$19 Million
Previous $29.7 Billion
32.11%
% of portfolio
0.88%
Previous 1.27%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,495Shares Held
85.9MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.24 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.75 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.25 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.18 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...